GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2026)

GE HealthCare Technologies' Capital Expenditures history runs 5 years deep, the most recent figure standing at $178.0 million for Q1 2026.

• Quarterly Capital Expenditures rose 106.98% year-over-year to $178.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $256.0 million (up 204.76% YoY) and the FY2025 annual result came in at $164.0 million, up 14.69% from the prior year.
• Capital Expenditures was $178.0 million for Q1 2026 at GE HealthCare Technologies, up from $53.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $223.0 million in Q3 2023 and bottomed at -$153.0 million in Q4 2023.
• A 5-year average of $44.8 million and a median of $59.0 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2023 — Capital Expenditures slumped 223.73% — and 2025, when it soared 625.0%.
• GE HealthCare Technologies' Capital Expenditures stood at -$97.0 million in 2022, then slumped by 57.73% to -$153.0 million in 2023, then jumped by 146.41% to $71.0 million in 2024, then retreated by 25.35% to $53.0 million in 2025, then soared by 235.85% to $178.0 million in 2026.
• Business Quant data shows GEHC's Capital Expenditures at $178.0 million in Q1 2026, $53.0 million in Q4 2025, and $21.0 million in Q3 2025.